Pain in neurologic disease: Guillain-Barré, multiple sclerosis and Parkinson
Neuropathic pain · C8 · Reviewed by a board-certified pain physician on November 2, 2026
Bottom line
Pain is common in neurologic disease and often follows the disease's own pattern: Guillain-Barré pain can come before weakness, multiple sclerosis can cause secondary trigeminal neuralgia, and Parkinson pain often tracks levodopa off periods.
Key points
- Guillain-Barré pain is frequent and early. Weakness usually starts in the legs with reduced reflexes; pain is frequent, can be muscular, radicular or neuropathic, and severe diffuse pain can precede the onset of weakness 1.
- Pain persists through the course. In a prospective cohort of 156 patients, 36% had pain in the 2 weeks before weakness, 66% in the acute phase and 38% after 1 year 2.
- Watch breathing in the first week. Up to 22% of patients need mechanical ventilation within the first week, so those at risk of respiratory failure must be identified early 1.
- Image every trigeminal neuralgia. The European Academy of Neurology recommends MRI with three high-resolution sequences because no clinical characteristic can exclude secondary trigeminal neuralgia 3.
- Multiple sclerosis is a classified cause. ICHD-3 lists trigeminal neuralgia attributed to multiple sclerosis among the secondary forms 4.
- Parkinson pain follows motor fluctuations. Classifications include off-period pain and painful dystonia, such as early-morning dystonia, in patients with fluctuating responses to levodopa 5.
Watch for
Severe back or limb pain with progressive bilateral weakness and reduced or absent reflexes suggests Guillain-Barré syndrome; monitor for respiratory insufficiency rather than treating it as radiculopathy 1.
High-yield for the exam
- Guillain-Barré weakness typically starts in the legs; reflexes are reduced or absent in most patients at presentation and in almost all at nadir 1.
- Maximum disability is typically reached within 2 weeks; reaching it within 24 hours or after 4 weeks suggests another diagnosis 1.
- Young children with Guillain-Barré syndrome may present with poorly localized pain, refusal to bear weight or an unsteady gait 1.
- Signs of imminent respiratory insufficiency include breathlessness at rest or while talking, inability to count to 15 in one breath and accessory muscle use 1.
- Mean pain intensity was highest in patients with sensory disturbances and in severely affected patients 2.
- Secondary trigeminal neuralgia is generally treated like primary, with carbamazepine or oxcarbazepine as first-choice drugs 3.
- Pain affects 68–85% of people with Parkinson disease and is underdiagnosed and undertreated 5.
- Levodopa reversed the lower pain threshold of the off state, and rotigotine gave a 2-fold improvement in fluctuation-related pain versus placebo 5.
Numbers to know
Common traps
- Attributing back and leg pain with areflexic weakness to disc disease 1.
- Skipping MRI because trigeminal attacks look typical 3.
- Adding neuropathic drugs for Parkinson pain that tracks the timing of levodopa doses 5.
- Assuming Guillain-Barré pain ends as strength returns; over a third still have pain at 1 year 2.
Practise this topic
3 more questions on this topic in the full question bank, with explanations and sources.
Sources
- Leonhard SE, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol, 2019. pmc.ncbi.nlm.nih.gov/articles/PMC6821638/
- Ruts L, et al. Pain in Guillain-Barre syndrome: a long-term follow-up study. Neurology, 2010. pubmed.ncbi.nlm.nih.gov/20861454/
- Bendtsen L, et al. European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol, 2019. pubmed.ncbi.nlm.nih.gov/30860637/
- International Headache Society. ICHD-3: 13.1 Pain attributed to a lesion or disease of the trigeminal nerve. ichd-3.org, accessed 2026. ichd-3.org/13-painful-cranial-neuropathies-and-other-facial-
- Lawn T, et al. Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease. Pain, 2021. pmc.ncbi.nlm.nih.gov/articles/PMC7977618/
Related topics
Independent study material for the ABA Pain Medicine exam, written and reviewed by a board-certified pain physician. Not medical advice; not affiliated with the American Board of Anesthesiology.